CMV allograft pancreatitis - Diagnosis, treatment, and histological features

被引:29
作者
Klassen, DK
Drachenberg, CB
Papadimitriou, JC
Cangro, CB
Fink, JC
Bartlett, ST
Weir, MR
机构
[1] Univ Maryland, Div Nephrol, Dept Med, Baltimore, MD 21201 USA
[2] Univ Maryland, Dept Pathol, Baltimore, MD 21201 USA
[3] Univ Maryland, Dept Surg, Div Transplantat, Baltimore, MD 21201 USA
关键词
D O I
10.1097/00007890-200005150-00042
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Cytomegalovirus (CMV) infection is a common problem in solid organ transplant recipients. CMV infection of pancreas allografts is not, however, well described. Methods. We report the clinical presentation, histologic findings, treatment, and outcome in four patients with CMV allograft pancreatitis. These patients presented 18 weeks to 44 months after transplantation with elevated serum amylase and lipase and were suspected to have acute rejection. Percutaneous pancreas allograft biopsy specimens showed evidence of tissue invasive CMV infection. One patient had simultaneous CMV infection and acute rejection. Results. Prolonged treatment with ganciclovir resulted in clinical and histologic resolution of the CMV disease. Rejection was successfully treated. Primary CMV infection in seronegative recipients seemed to be a risk factor. Three patients maintain normal allograft function; one patient lost function due to chronic rejection. The histology of tissue-invasive CMV pancreas allograft infection and its differentiation from acute rejection is described. Conclusion. Prompt diagnosis and prolonged therapy with antiviral agents can result in maintenance of allograft function.
引用
收藏
页码:1968 / 1971
页数:4
相关论文
共 8 条
[1]  
BACKMAN L, 1991, TRANSPLANT INT, V4, P116
[2]   Evaluation of pancreas transplant needle biopsy - Reproducibility and revision of histologic grading system [J].
Drachenberg, CB ;
Papadimitriou, JC ;
Klassen, DK ;
Racusen, LC ;
HoehnSaric, EW ;
Weir, MR ;
Kuo, PC ;
Schweitzer, EJ ;
Johnson, LB ;
Bartlett, ST .
TRANSPLANTATION, 1997, 63 (11) :1579-1586
[3]   TREATMENT OF INVASIVE CYTOMEGALOVIRUS DISEASE IN SOLID ORGAN TRANSPLANT PATIENTS WITH GANCICLOVIR [J].
DUNN, DL ;
MAYORAL, JL ;
GILLINGHAM, KJ ;
LOEFFLER, CM ;
BRAYMAN, KL ;
KRAMER, MA ;
ERICE, A ;
BALFOUR, HH ;
FLETCHER, CV ;
BOLMAN, RM ;
MATAS, AJ ;
PAYNE, WD ;
SUTHERLAND, DER ;
NAJARIAN, JS .
TRANSPLANTATION, 1991, 51 (01) :98-106
[4]   Cytomegalovirus disease recurrence after ganciclovir treatment in kidney and kidney-pancreas transplant recipients [J].
Humar, A ;
Uknis, M ;
Carlone-Jambor, C ;
Gruessner, RW ;
Dunn, DL ;
Matas, A .
TRANSPLANTATION, 1999, 67 (01) :94-97
[5]   The clinical significance of cytomegaloviral inclusions in the allograft kidney [J].
Kashyap, R ;
Shapiro, R ;
Jordan, M ;
Randhawa, PS .
TRANSPLANTATION, 1999, 67 (01) :98-103
[6]  
MARGREITER R, 1991, TRANSPL P, V23, P1619
[7]   Histologic grading of acute allograft rejection in pancreas needle biopsy: Correlation to serum enzymes, glycemia, and response to immunosuppressive treatment [J].
Papadimitriou, JC ;
Drachenberg, CB ;
Wiland, A ;
Klassen, DK ;
Fink, J ;
Weir, MR ;
Cangro, C ;
Schweitzer, EJ ;
Bartlett, ST .
TRANSPLANTATION, 1998, 66 (12) :1741-1745
[8]   EFFECTS OF ANTI-THYMOCYTE GLOBULIN ON CYTOMEGALOVIRUS-INFECTION IN RENAL-TRANSPLANT RECIPIENTS [J].
RUBIN, RH ;
COSIMI, AB ;
HIRSCH, MS ;
HERRIN, JT ;
RUSSELL, PS ;
TOLKOFFRUBIN, NE .
TRANSPLANTATION, 1981, 31 (02) :143-145